TP53 and cancer: The prevalence of cells arresting in the G2/M phase has been previously associated with cancer cell proliferation, mutation of TP53 and KARS, T cell infiltration, and cancer metastasis (Oshi et al., 2020a; Oshi et al., 2020b; Jung et al., 2021).